173 related articles for article (PubMed ID: 37275454)
1. Oral fruquintinib combined with tegafur-gimeracil-oteracil potassium for advanced colorectal cancer to obtain longer progression-free survival: A case report.
Qu FJ; Wu S; Kong Y
World J Gastrointest Oncol; 2023 May; 15(5):902-910. PubMed ID: 37275454
[TBL] [Abstract][Full Text] [Related]
2. Tegafur + gimeracil + oteracil. Just another fluorouracil precursor.
Prescrire Int; 2013 May; 22(138):122. PubMed ID: 23819172
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of the efficacy and safety of capecitabine or tegafur, gimeracil and oteracil potassium capsules combined with oxaliplatin chemotherapy regimens in the treatment of advanced gastric cancer].
Wan Y; Hui H; Wang X; Wu J; Sun S
Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):28-34. PubMed ID: 26796803
[TBL] [Abstract][Full Text] [Related]
4. A fatal myelosuppression, diarrhea and neurotoxicity induced by combination of irinotecan and tegafur-gimeracil-oteracil potassium in the treatment of colon cancer: a case report.
Liu YX; Le KJ; Zhang C; Cui M; Zhou H; Su YJ; Gu ZC
Transl Cancer Res; 2020 Jan; 9(1):382-387. PubMed ID: 35117192
[TBL] [Abstract][Full Text] [Related]
5. Clinical study of tegafur-gimeracil-oteracil potassium capsule (s-1) and oxaliplatin combination chemotherapy in advanced colorectal cancer.
Liu H; Wang Y; Li G; Song W; Wang R
J Cancer Res Ther; 2015; 11(2):331-5. PubMed ID: 26148595
[TBL] [Abstract][Full Text] [Related]
6. Tegafur gimeracil oter combined with oxaliplatin for advanced colorectal cancer.
Yang ZH; Ren J; Yi LJ; Zheng JH; Wei H
Eur Rev Med Pharmacol Sci; 2015 Sep; 19(18):3391-6. PubMed ID: 26439033
[TBL] [Abstract][Full Text] [Related]
7. Preliminary experience of oral fruquintinib-capecitabine as a new maintenance treatment strategy for advanced colorectal cancer in the era of coronavirus disease 2019 (COVID-19): case report and literature review.
Quan M; Chen Z; Chen J; Hai Y; Gao Y
J Gastrointest Oncol; 2022 Oct; 13(5):2660-2666. PubMed ID: 36388683
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of apatinib combined with tegafur gimeracil and oteracil potassium in the second-line treatment of advanced gastric cancer.
Chen H; Xue L; Liu L; Li P
J BUON; 2021; 26(3):917-923. PubMed ID: 34268954
[TBL] [Abstract][Full Text] [Related]
9. Effect of celecoxib combined with chemotherapy drug on malignant biological behaviors of gastric cancer.
Meng C; Lu Z; Fang M; Zhou X; Dai K; Zhang S; Luo J; Luo Z
Int J Clin Exp Pathol; 2014; 7(11):7622-32. PubMed ID: 25550798
[TBL] [Abstract][Full Text] [Related]
10. Case Report: A Case of Locally Advanced Pancreatic Cancer Which Achieved Progression Free for Over 12 Months by Subsequent Therapy with Anlotinib Hydrochloride Plus Tegafur-Gimeracil-Oteracil Potassium (TS-1).
Luo D; Liao S; Li Q; Lin Y; Wei J; Li Y; Liao X
Front Oncol; 2022; 12():862600. PubMed ID: 35847852
[TBL] [Abstract][Full Text] [Related]
11. The Clinical Evaluation of Tegafur Gimeracil Oteracil Combined with THP and DDP for Second-Line Treatment of Advanced Cardiac Carcinoma.
Wang HF; Lv JQ
Cell Biochem Biophys; 2015 Jul; 72(3):695-9. PubMed ID: 25618173
[TBL] [Abstract][Full Text] [Related]
12. Short-term clinical effect of conformal radiotherapy combined with tegafur gimeracil oteracil potassium in treating recurrent esophagus cancer.
Jiao Y; Shen Y; Yan H; Liu Y; Tan H; Li J
Pak J Med Sci; 2016; 32(5):1141-1145. PubMed ID: 27882010
[TBL] [Abstract][Full Text] [Related]
13. Using a combination of fruquintinib, raltitrexed, and S-1 as a third-line treatment for metastatic colorectal cancer with co-existence of Hodgkin lymphoma: a case report.
Wan Y; Luo D
J Gastrointest Oncol; 2023 Feb; 14(1):450-457. PubMed ID: 36915460
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of S-1 (tegafur, gimeracil, and oteracil potassium) concurrent with 3-dimensional conformal radiotherapy for newly diagnosed squamous cell carcinoma of the lung in elderly patients.
Wang T; Zhang SF; Qiu MQ; Li QL
Cancer Radiother; 2016 May; 20(3):181-6. PubMed ID: 27068497
[TBL] [Abstract][Full Text] [Related]
15. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
Abdel-Rahman O; Elsayed Z; Elhalawani H
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
[TBL] [Abstract][Full Text] [Related]
16. [Inhibitive effect of celecoxib combined with tegafur gimeracil oteracil potassium on the growth of xenograft tumor of gastric cancer in nude mice].
Meng C; Chen X; Luo Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 May; 29(5):458-61. PubMed ID: 23643260
[TBL] [Abstract][Full Text] [Related]
17. Fruquintinib for refractory colorectal cancer in a pre-treated 82-year-old patient achieved a progression-free survival of 25 months: a case report.
Wang Y; Li J; Xu Q; Li K; Zhang C; Chen P
J Gastrointest Oncol; 2022 Oct; 13(5):2667-2671. PubMed ID: 36388671
[TBL] [Abstract][Full Text] [Related]
18. Phase II clinical trial of metronomic chemotherapy with combined irinotecan and tegafur-gimeracil-oteracil potassium in metastatic and recurrent breast cancer.
Otsuka H; Fujii T; Toh U; Iwakuma N; Takahashi R; Mishima M; Takenaka M; Kakuma T; Tanaka M; Shirouzu K
Breast Cancer; 2015 Jul; 22(4):335-42. PubMed ID: 23827973
[TBL] [Abstract][Full Text] [Related]
19. The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation.
Hind D; Tappenden P; Tumur I; Eggington S; Sutcliffe P; Ryan A
Health Technol Assess; 2008 May; 12(15):iii-ix, xi-162. PubMed ID: 18462574
[TBL] [Abstract][Full Text] [Related]
20. Nab-paclitaxel plus tegafur gimeracil oteracil potassium capsule (S-1) as first-line treatment for advanced biliary tract adenocarcinoma: a phase 2 clinical trial.
Zhang W; Sun Y; Jiang Z; Qu W; Gong C; Zhou A
Hepatobiliary Surg Nutr; 2023 Feb; 12(1):37-44. PubMed ID: 36860259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]